Back to Authors

Boardman, Lisa A.

Mayo Clinic

Mayo Clinic

Citations 1

Higher Frequency of Diploidy in Young-Onset Microsatellite-Stable Colorectal Cancer
Boardman, Lisa A., Johnson, Ruth, Petersen, Gloria M. , Oberg, Ann L. , Kabat, Brian, Slusser, Joshua P. , Morlan, Bruce W., French, Amy J. , Smyrk, Thomas C. , Lindor, Noralane M. , Thibodeau, Stephen N. , Boardman, Lisa A., Wang, Liang

Clinical Cancer Research | April 16, 2007 | Volume: 13 | Issue: 8 | Pages: 2323-2328

10.1158/1078-0432.ccr-06-2739 Get It

AbstractPurpose: Colorectal carcinoma (CRC) can be divided into two nonoverlapping groups: those that are chromosomally unstable but microsatellite stable (MSS CIN+) and those that are chromosomally stable but microsatellite unstable (MSI CIN−). However, a third group with neither chromosome nor microsatellite instability (MSS CIN−) makes a substantial contribution to the total CRC burden. The clinicopathologic features of MSS CIN− CRC are not well delineated. We assessed the relationship between age and chromosomal instability (CIN) status as measured by ploidy and allelic imbalance in a series of MSS tumors.Experimental Design: We studied a prospectively collected series of CRC patients at Mayo Clinic Rochester. A total of 84 samples of MSS CRC in patients ≤50 years old were identified between 1994 and 1997. A consecutive series of 90 MSS CRC in patients ≥65 years old served as a comparison group. CIN status was assessed using two techniques: ploidy analysis by flow cytometry and small chromosome changes as measured by genomewide fractional allelic imbalance.Results: CRC in the young-onset group was more likely to involve the rectum and to be high stage. MSS tumors in the young-onset group were more often diploid (46%) than those in older patients (26%; P = 0.006). This difference was maintained in the subset of MSS CRC that were high stage (42% versus 18%; P = 0.02) and in rectal cancers (50% versus 23%; P = 0.04).Conclusion: A greater proportion of young patients with MSS CRC has diploid tumors than patients who develop MSS CRC over age 65.